Sirolimus Dose Requirement in Kidney Transplant Recipients in Iran.
CONCLUSION: In a significant number of patients changing CNI to Sirolimus accompanied by GFR improvement. Contrary to the recommended dose of Sirolimus in the references (2 to 5 mg/d) Iranian kidney transplant recipients needed lower daily doses of Sirolimus (1.2 mg/d) to achieve the desired whole blood level. Further studies are recommended to confirm it.
PMID: 33277457 [PubMed - as supplied by publisher]
Source: Iranian Journal of Kidney Diseases - Category: Urology & Nephrology Tags: Iran J Kidney Dis Source Type: research
More News: Iran Health | Kidney Transplant | Kidney Transplantation | Middle East Health | Study | Transplant Surgery | Transplants | Urology & Nephrology